Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 14, 2005; 11(22): 3339-3345
Published online Jun 14, 2005. doi: 10.3748/wjg.v11.i22.3339
Published online Jun 14, 2005. doi: 10.3748/wjg.v11.i22.3339
Table 2 Results of cytotoxicity of CIK to target cells.
| Patient Number | A value (rate of cytotoxicity) | |||
| 7402/sb(%) | 7402/Rd(%) | L-02bd(%) | E control | |
| 1 | 0.802 (33) | 0.743 (49) | 1.011 (12) | 0.485 |
| 2 | 0.913 (48) | 0.895 (47) | 1.201 (4) | 0.627 |
| 3 | 0.681 (46) | 0.599 (57) | 0.888 (14) | 0.379 |
| 4 | 0.630 (68) | 0.602 (60) | 0.959 (7) | 0.401 |
| 5 | 0.711 (58) | 0.802 (37) | 1.001 (12) | 0.479 |
| 6 | 0.987 (51) | 0.903 (64) | 1.302 (2) | 0.718 |
| T control | 0.554 | 0.508 | 0.595 | |
- Citation: Zhang YS, Yuan FJ, Jia GF, Zhang JF, Hu LY, Huang L, Wang J, Dai ZQ. CIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402/R. World J Gastroenterol 2005; 11(22): 3339-3345
- URL: https://www.wjgnet.com/1007-9327/full/v11/i22/3339.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i22.3339